David Hou Awarded 2022 ABTA Lucien Rubinstein Award for ‘B Cell Vaccine Promotes Anti-Glioma Immunity Through Modulating CD8+ T Cells’
David Hou is awarded for his research on leveraging a B cell vaccine to improve immunotherapy treatment for GBM.
What is your brain tumor story? Click here to share it and join the community!
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
David Hou is awarded for his research on leveraging a B cell vaccine to improve immunotherapy treatment for GBM.
Kaitlin Stitz is awarded for her research on overcoming radioresistance in treatment of high risk pediatric tumors, which she conducted during her ABTA Medical Student Summer Fellowship.